{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:39:58Z","timestamp":1793936398586,"version":"4.8.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:00:00Z","timestamp":1722038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:00:00Z","timestamp":1722038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-50754-7","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T21:01:34Z","timestamp":1722114094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Targeting myeloid-derived suppressor cells promotes antiparasitic T-cell immunity and enhances the efficacy of PD-1 blockade"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3241-2224","authenticated-orcid":false,"given":"Chuanshan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9308-6186","authenticated-orcid":false,"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuerganaili","family":"Aji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhide","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinshi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abidan","family":"Ainiwaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zibigu","family":"Rousu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maolin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingqing","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adilai","family":"duolikun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejiao","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuran","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingmei","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique A.","family":"Vuitton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5512-6378","authenticated-orcid":false,"given":"Zhigang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7506-8806","authenticated-orcid":false,"given":"Haoyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7144-220X","authenticated-orcid":false,"given":"Hao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,27]]},"reference":[{"key":"50754_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.coi.2019.04.014","volume":"58","author":"M Philip","year":"2019","unstructured":"Philip, M. & Schietinger, A. Heterogeneity and fate choice: T cell exhaustion in cancer and chronic infections. Curr. Opin. Immunol. 58, 98\u2013103 (2019).","journal-title":"Curr. Opin. Immunol."},{"key":"50754_CR2","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","volume":"19","author":"CU Blank","year":"2019","unstructured":"Blank, C. U. et al. Defining \u2018T cell exhaustion\u2019. Nat. Rev. Immunol. 19, 665\u2013674 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"50754_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.4049\/jimmunol.1701044","volume":"200","author":"MW LaFleur","year":"2018","unstructured":"LaFleur, M. W., Muroyama, Y., Drake, C. G. & Sharpe, A. H. Inhibitors of the PD-1 pathway in tumor therapy. J. Immunol. 200, 375\u2013383 (2018).","journal-title":"J. Immunol."},{"key":"50754_CR4","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1053\/j.seminoncol.2019.10.002","volume":"46","author":"AM Hopkins","year":"2019","unstructured":"Hopkins, A. M., Kichenadasse, G., McKinnon, R. A., Rowland, A. & Sorich, M. J. Baseline tumor size and survival outcomes in lung cancer patients treated with immune checkpoint inhibitors. Semin. Oncol. 46, 380\u2013384 (2019).","journal-title":"Semin. Oncol."},{"key":"50754_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-014-0040-2","volume":"2","author":"M Nishino","year":"2014","unstructured":"Nishino, M., Giobbie-Hurder, A., Ramaiya, N. H. & Hodi, F. S. Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome. J. Immunother. Cancer 2, 40 (2014).","journal-title":"J. Immunother. Cancer"},{"key":"50754_CR6","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma, P., Hu-Lieskovan, S., Wargo, J. A. & Ribas, A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168, 707\u2013723 (2017).","journal-title":"Cell"},{"key":"50754_CR7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3389\/fimmu.2020.00487","volume":"11","author":"JM Jubel","year":"2020","unstructured":"Jubel, J. M., Barbati, Z. R., Burger, C., Wirtz, D. C. & Schildberg, F. A. The role of PD-1 in acute and chronic infection. Front. Immunol. 11, 487 (2020).","journal-title":"Front. Immunol."},{"key":"50754_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11703-1","volume":"7","author":"C Zhang","year":"2017","unstructured":"Zhang, C. et al. T-cell tolerance and exhaustion in the clearance of Echinococcus multilocularis: role of inoculum size in a quantitative hepatic experimental model. Sci. Rep. 7, 11153 (2017).","journal-title":"Sci. Rep."},{"key":"50754_CR9","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1002\/hep.30896","volume":"71","author":"C Zhang","year":"2020","unstructured":"Zhang, C. et al. Immune exhaustion of T cells in alveolar echinococcosis patients and its reversal by blocking checkpoint receptor TIGIT in a murine model. Hepatology 71, 1297\u20131315 (2020).","journal-title":"Hepatology"},{"key":"50754_CR10","doi-asserted-by":"publisher","first-page":"e1011396","DOI":"10.1371\/journal.ppat.1011396","volume":"19","author":"D Li","year":"2023","unstructured":"Li, D. et al. Upregulation of LAG3 modulates the immune imbalance of CD4+ T-cell subsets and exacerbates disease progression in patients with alveolar echinococcosis and a mouse model. PLoS Pathog. 19, e1011396 (2023).","journal-title":"PLoS Pathog."},{"key":"50754_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/pim.12834","volume":"43","author":"F Jebbawi","year":"2021","unstructured":"Jebbawi, F. et al. Innate and adaptive immune responses following PD-L1 blockade in treating chronic murine alveolar echinococcosis. Parasite Immunol. 43, e12834 (2021).","journal-title":"Parasite Immunol."},{"key":"50754_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/pim.12596","volume":"40","author":"J Wang","year":"2018","unstructured":"Wang, J. et al. Immunotherapy of alveolar echinococcosis via PD-1\/PD-L1 immune checkpoint blockade in mice. Parasite Immunol. 40, e12596 (2018).","journal-title":"Parasite Immunol."},{"key":"50754_CR13","doi-asserted-by":"crossref","unstructured":"Wen, H. et al. Echinococcosis: Advances in the 21st Century. Clin. Microbiol. Rev. 32, e00075 (2019).","DOI":"10.1128\/CMR.00075-18"},{"key":"50754_CR14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.cmi.2022.12.010","volume":"29","author":"B Autier","year":"2023","unstructured":"Autier, B. et al. Alveolar echinococcosis in immunocompromised hosts. Clin. Microbiol. Infect. 29, 593\u2013599 (2023).","journal-title":"Clin. Microbiol. Infect."},{"key":"50754_CR15","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1128\/IAI.70.3.1168-1174.2002","volume":"70","author":"BJ Manfras","year":"2002","unstructured":"Manfras, B. J., Reuter, S., Wendland, T. & Kern, P. Increased activation and oligoclonality of peripheral CD8(+) T cells in the chronic human helminth infection alveolar echinococcosis. Infect. immun. 70, 1168\u20131174 (2002).","journal-title":"Infect. immun."},{"key":"50754_CR16","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1093\/cid\/ciu520","volume":"59","author":"A Chauchet","year":"2014","unstructured":"Chauchet, A. et al. Increased incidence and characteristics of alveolar echinococcosis in patients with immunosuppression-associated conditions. Clin. Infect. Dis. 59, 1095\u20131104 (2014).","journal-title":"Clin. Infect. Dis."},{"key":"50754_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/vaccines4040036","volume":"4","author":"V Umansky","year":"2016","unstructured":"Umansky, V., Blattner, C., Gebhardt, C. & Utikal, J. The role of myeloid-derived suppressor cells (MDSC) in cancer progression. Vaccines 4, 36 (2016).","journal-title":"Vaccines"},{"key":"50754_CR18","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nri1668","volume":"5","author":"V Bronte","year":"2005","unstructured":"Bronte, V. & Zanovello, P. Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol. 5, 641\u2013654 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"50754_CR19","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1600-065X.2008.00608.x","volume":"222","author":"PC Rodriguez","year":"2008","unstructured":"Rodriguez, P. C. & Ochoa, A. C. Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol. Rev. 222, 180\u2013191 (2008).","journal-title":"Immunol. Rev."},{"key":"50754_CR20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.4049\/jimmunol.1800180","volume":"201","author":"C Onyilagha","year":"2018","unstructured":"Onyilagha, C., Kuriakose, S., Ikeogu, N., Jia, P. & Uzonna, J. Myeloid-derived suppressor cells Contribute to susceptibility to trypanosoma congolense infection by suppressing CD4(+) T cell proliferation and IFN-gamma production. J. Immunol. 201, 507\u2013515 (2018).","journal-title":"J. Immunol."},{"key":"50754_CR21","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.4049\/jimmunol.1201449","volume":"190","author":"J Yu","year":"2013","unstructured":"Yu, J. et al. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer. J. Immunol. 190, 3783\u20133797 (2013).","journal-title":"J. Immunol."},{"key":"50754_CR22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","volume":"19","author":"F Veglia","year":"2018","unstructured":"Veglia, F., Perego, M. & Gabrilovich, D. Myeloid-derived suppressor cells coming of age. Nat. Immunol. 19, 108\u2013119 (2018).","journal-title":"Nat. Immunol."},{"key":"50754_CR23","doi-asserted-by":"publisher","first-page":"237ra267","DOI":"10.1126\/scitranslmed.3007974","volume":"6","author":"SL Highfill","year":"2014","unstructured":"Highfill, S. L. et al. Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy. Sci. Transl. Med. 6, 237ra267 (2014).","journal-title":"Sci. Transl. Med."},{"key":"50754_CR24","doi-asserted-by":"crossref","unstructured":"Bao, Y. et al. Targeting m(6)A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer. Gut 72, 1497\u20131509 (2023).","DOI":"10.1136\/gutjnl-2022-328845"},{"key":"50754_CR25","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1053\/j.gastro.2020.10.036","volume":"160","author":"W Kim","year":"2021","unstructured":"Kim, W. et al. PD-1 Signaling promotes tumor-infiltrating myeloid-derived suppressor cells and gastric tumorigenesis in mice. Gastroenterology 160, 781\u2013796 (2021).","journal-title":"Gastroenterology"},{"key":"50754_CR26","doi-asserted-by":"publisher","first-page":"874308","DOI":"10.3389\/fimmu.2022.874308","volume":"13","author":"MM Stevenson","year":"2022","unstructured":"Stevenson, M. M., Valanparambil, R. M. & Tam, M. Myeloid-derived suppressor cells: The expanding world of helminth modulation of the immune system. Front. Immunol. 13, 874308 (2022).","journal-title":"Front. Immunol."},{"key":"50754_CR27","doi-asserted-by":"publisher","first-page":"e59746","DOI":"10.1371\/journal.pone.0059746","volume":"8","author":"W Pan","year":"2013","unstructured":"Pan, W. et al. Surveillance on the status of immune cells after Echinnococcus granulosus protoscoleces infection in Balb\/c mice. PloS ONE 8, e59746 (2013).","journal-title":"PloS ONE"},{"key":"50754_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.exppara.2020.107917","volume":"215","author":"X Zhou","year":"2020","unstructured":"Zhou, X. et al. Myeloid-derived suppressor cells exert immunosuppressive function on the T helper 2 in mice infected with Echinococcus granulosus. Exp. Parasitol. 215, 107917 (2020).","journal-title":"Exp. Parasitol."},{"key":"50754_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1126\/science.272.5258.54","volume":"272","author":"R Ahmed","year":"1996","unstructured":"Ahmed, R. & Gray, D. Immunological memory and protective immunity: understanding their relation. Science 272, 54\u201360 (1996).","journal-title":"Science"},{"key":"50754_CR30","doi-asserted-by":"publisher","first-page":"511","DOI":"10.4049\/jimmunol.177.1.511","volume":"177","author":"C Zaph","year":"2006","unstructured":"Zaph, C. et al. Persistence and function of central and effector memory CD4+ T cells following infection with a gastrointestinal helminth. J. Immunol. 177, 511\u2013518 (2006).","journal-title":"J. Immunol."},{"key":"50754_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.imlet.2014.03.011","volume":"161","author":"U Krzych","year":"2014","unstructured":"Krzych, U., Zarling, S. & Pichugin, A. Memory T cells maintain protracted protection against malaria. Immunol. Lett. 161, 189\u2013195 (2014).","journal-title":"Immunol. Lett."},{"key":"50754_CR32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev.immunol.18.1.275","volume":"18","author":"JT Harty","year":"2000","unstructured":"Harty, J. T., Tvinnereim, A. R. & White, D. W. CD8+ T cell effector mechanisms in resistance to infection. Annu. Rev. Immunol. 18, 275\u2013308 (2000).","journal-title":"Annu. Rev. Immunol."},{"key":"50754_CR33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.it.2015.02.008","volume":"36","author":"KE Pauken","year":"2015","unstructured":"Pauken, K. E. & Wherry, E. J. Overcoming T cell exhaustion in infection and cancer. Trends Immunol. 36, 265\u2013276 (2015).","journal-title":"Trends Immunol."},{"key":"50754_CR34","doi-asserted-by":"publisher","first-page":"e0008909","DOI":"10.1371\/journal.pntd.0008909","volume":"14","author":"L Lu","year":"2020","unstructured":"Lu, L. et al. Loss of natural resistance to schistosome in T cell deficient rat. PLoS Negl. Trop. Dis. 14, e0008909 (2020).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"50754_CR35","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.intimp.2015.04.013","volume":"26","author":"X La","year":"2015","unstructured":"La, X. et al. Upregulation of PD-1 on CD4(+)CD25(+) T cells is associated with immunosuppression in liver of mice infected with Echinococcus multilocularis. Int. Immunopharmacol. 26, 357\u2013366 (2015).","journal-title":"Int. Immunopharmacol."},{"key":"50754_CR36","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3892\/etm.2015.2876","volume":"11","author":"Y Li","year":"2016","unstructured":"Li, Y. et al. Role of soluble programmed death-1 (sPD-1) and sPD-ligand 1 in patients with cystic echinococcosis. Exp. Ther. Med. 11, 251\u2013256 (2016).","journal-title":"Exp. Ther. Med."},{"key":"50754_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/pim.12809","volume":"43","author":"E Ben Salah","year":"2021","unstructured":"Ben Salah, E. et al. Soluble programmed death-1 (sPD-1) as predictor of early surgical outcomes of paediatric cystic echinococcosis. Parasite Immunol. 43, e12809 (2021).","journal-title":"Parasite Immunol."},{"key":"50754_CR38","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1001\/jama.2016.4059","volume":"315","author":"A Ribas","year":"2016","unstructured":"Ribas, A. et al. Association of pembrolizumab with tumor response and survival among patients with advanced melanoma. JAMA 315, 1600\u20131609 (2016).","journal-title":"JAMA"},{"key":"50754_CR39","doi-asserted-by":"publisher","first-page":"e96836","DOI":"10.1172\/jci.insight.96836","volume":"3","author":"GJ Markowitz","year":"2018","unstructured":"Markowitz, G. J. et al. Immune reprogramming via PD-1 inhibition enhances early-stage lung cancer survival. JCI Insight 3, e96836 (2018).","journal-title":"JCI Insight"},{"key":"50754_CR40","doi-asserted-by":"publisher","first-page":"eabf3861","DOI":"10.1126\/sciimmunol.abf3861","volume":"6","author":"KD Kauffman","year":"2021","unstructured":"Kauffman, K. D. et al. PD-1 blockade exacerbates Mycobacterium tuberculosis infection in rhesus macaques. Sci. Immunol. 6, eabf3861 (2021).","journal-title":"Sci. Immunol."},{"key":"50754_CR41","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1053\/j.gastro.2008.02.033","volume":"134","author":"N Nakamoto","year":"2008","unstructured":"Nakamoto, N. et al. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization. Gastroenterology 134, 1927\u20131937 (2008).","journal-title":"Gastroenterology"},{"key":"50754_CR42","doi-asserted-by":"crossref","unstructured":"Chardin, D. et al. Baseline metabolic tumor volume as a strong predictive and prognostic biomarker in patients with non-small cell lung cancer treated with PD1 inhibitors: a prospective study. J. Immunother. Cancer 8, e000645 (2020).","DOI":"10.1136\/jitc-2020-000645"},{"key":"50754_CR43","doi-asserted-by":"publisher","first-page":"4960","DOI":"10.1158\/1078-0432.CCR-17-2386","volume":"24","author":"RW Joseph","year":"2018","unstructured":"Joseph, R. W. et al. Baseline tumor size is an independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab. Clin. Cancer Res. 24, 4960\u20134967 (2018).","journal-title":"Clin. Cancer Res."},{"key":"50754_CR44","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/cac2.12420","volume":"43","author":"Z Wen","year":"2023","unstructured":"Wen, Z. et al. High baseline tumor burden-associated macrophages promote an immunosuppressive microenvironment and reduce the efficacy of immune checkpoint inhibitors through the IGFBP2-STAT3-PD-L1 pathway. Cancer Commun. 43, 562\u2013581 (2023).","journal-title":"Cancer Commun."},{"key":"50754_CR45","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/jvh.13108","volume":"26","author":"K Caraballo Cortes","year":"2019","unstructured":"Caraballo Cortes, K. et al. Expression of programmed cell death protein 1 and T-cell immunoglobulin- and mucin-domain-containing molecule-3 on peripheral blood CD4+CD8+ double positive T cells in patients with chronic hepatitis C virus infection and in subjects who spontaneously cleared the virus. J. Viral Hepat. 26, 942\u2013950 (2019).","journal-title":"J. Viral Hepat."},{"key":"50754_CR46","first-page":"5985131","volume":"2018","author":"A Pandey","year":"2018","unstructured":"Pandey, A., Ezemenari, S., Liaukovich, M., Richard, I. & Boris, A. A rare case of pembrolizumab-induced reactivation of hepatitis B. Case Rep. Oncol. Med. 2018, 5985131 (2018).","journal-title":"Case Rep. Oncol. Med."},{"key":"50754_CR47","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/cmi.2016.3","volume":"13","author":"MW Robinson","year":"2016","unstructured":"Robinson, M. W., Harmon, C. & O\u2019Farrelly, C. Liver immunology and its role in inflammation and homeostasis. Cell. Mol. Immunol. 13, 267\u2013276 (2016).","journal-title":"Cell. Mol. Immunol."},{"key":"50754_CR48","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1172\/JCI96107","volume":"128","author":"A Petrelli","year":"2018","unstructured":"Petrelli, A. et al. PD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation. J. Clin.Invest. 128, 4669\u20134681 (2018).","journal-title":"J. Clin.Invest."},{"key":"50754_CR49","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/icb.2017.62","volume":"95","author":"Shwetank","year":"2017","unstructured":"Shwetank et al. Maintenance of PD-1 on brain-resident memory CD8 T cells is antigen independent. Immunol. Cell Biol. 95, 953\u2013959 (2017).","journal-title":"Immunol. Cell Biol."},{"key":"50754_CR50","doi-asserted-by":"publisher","first-page":"755304","DOI":"10.3389\/fimmu.2021.755304","volume":"12","author":"S Gitto","year":"2021","unstructured":"Gitto, S., Natalini, A., Antonangeli, F. & Di Rosa, F. The Emerging Interplay Between Recirculating and Tissue-Resident Memory T Cells in Cancer. Front. Immunol. 12, 755304 (2021).","journal-title":"Front. Immunol."},{"key":"50754_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0399-6","volume":"6","author":"F Mami-Chouaib","year":"2018","unstructured":"Mami-Chouaib, F. et al. Resident memory T cells, critical components in tumor immunology. J. Immunother. Cancer 6, 87 (2018).","journal-title":"J. Immunother. Cancer"},{"key":"50754_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/srep15948","volume":"5","author":"QQ Zhang","year":"2015","unstructured":"Zhang, Q. Q. et al. CD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment. Sci. Rep. 5, 15948 (2015).","journal-title":"Sci. Rep."},{"key":"50754_CR53","doi-asserted-by":"publisher","first-page":"100643","DOI":"10.1016\/j.ctarc.2022.100643","volume":"33","author":"H Abushukair","year":"2022","unstructured":"Abushukair, H., Ababneh, O., Zaitoun, S. & Saeed, A. Primary and secondary immune checkpoint inhibitors resistance in colorectal cancer: Key mechanisms and ways to overcome resistance. Cancer Treat. Res. Commun. 33, 100643 (2022).","journal-title":"Cancer Treat. Res. Commun."},{"key":"50754_CR54","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jhep.2022.02.019","volume":"77","author":"CY Wei","year":"2022","unstructured":"Wei, C. Y. et al. PKCalpha\/ZFP64\/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma. J. Hepatol. 77, 163\u2013176 (2022).","journal-title":"J. Hepatol."},{"key":"50754_CR55","doi-asserted-by":"publisher","first-page":"779","DOI":"10.4049\/jimmunol.165.2.779","volume":"165","author":"SA Kusmartsev","year":"2000","unstructured":"Kusmartsev, S. A., Li, Y. & Chen, S. H. Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3\/CD28 costimulation. J. Immunol. 165, 779\u2013785 (2000).","journal-title":"J. Immunol."},{"key":"50754_CR56","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1158\/0008-5472.CAN-09-2587","volume":"70","author":"MK Srivastava","year":"2010","unstructured":"Srivastava, M. K., Sinha, P., Clements, V. K., Rodriguez, P. & Ostrand-Rosenberg, S. Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res. 70, 68\u201377 (2010).","journal-title":"Cancer Res."},{"key":"50754_CR57","doi-asserted-by":"publisher","first-page":"1039244","DOI":"10.3389\/fimmu.2023.1039244","volume":"14","author":"NW Preite","year":"2023","unstructured":"Preite, N. W., Kaminski, V. L., Borges, B. M., Calich, V. L. G. & Loures, F. V. Myeloid-derived suppressor cells are associated with impaired Th1 and Th17 responses and severe pulmonary paracoccidioidomycosis which is reversed by anti-Gr1 therapy. Front. Immunol. 14, 1039244 (2023).","journal-title":"Front. Immunol."},{"key":"50754_CR58","doi-asserted-by":"publisher","first-page":"e167951","DOI":"10.1172\/JCI167951","volume":"133","author":"A Ajith","year":"2023","unstructured":"Ajith, A. et al. Targeting TREM1 augments antitumor T cell immunity by inhibiting myeloid-derived suppressor cells and restraining anti-PD-1 resistance. J. Clin. Invest. 133, e167951 (2023).","journal-title":"J. Clin. Invest."},{"key":"50754_CR59","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1365-3083.2007.01958.x","volume":"66","author":"CR Marinho","year":"2007","unstructured":"Marinho, C. R. et al. IFN-gamma, but not nitric oxide or specific IgG, is essential for the in vivo control of low-virulence Sylvio X10\/4 Trypanosoma cruzi parasites. Scand. J. Immunol. 66, 297\u2013308 (2007).","journal-title":"Scand. J. Immunol."},{"key":"50754_CR60","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1093\/clinids\/20.6.1543","volume":"20","author":"M Schmid","year":"1995","unstructured":"Schmid, M. et al. Use of interferon gamma and mebendazole to stop the progression of alveolar hydatid disease: case report. Clin. Infect. Dis. 20, 1543\u20131546 (1995).","journal-title":"Clin. Infect. Dis."},{"key":"50754_CR61","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1086\/516316","volume":"26","author":"L Jenne","year":"1998","unstructured":"Jenne, L., Kilwinski, J., Radloff, P., Flick, W. & Kern, P. Clinical efficacy of and immunologic alterations caused by interferon gamma therapy for alveolar echinococcosis. Clin. Infect. Dis. 26, 492\u2013494 (1998).","journal-title":"Clin. Infect. Dis."},{"key":"50754_CR62","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1051\/parasite\/1998053231","volume":"5","author":"M Liance","year":"1998","unstructured":"Liance, M., Ricard-Blum, S., Emery, I., Houin, R. & Vuitton, D. A. Echinococcus multilocularis infection in mice: in vivo treatment with a low dose of IFN-gamma decreases metacestode growth and liver fibrogenesis. Parasite 5, 231\u2013237 (1998).","journal-title":"Parasite"},{"key":"50754_CR63","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1002\/hep.32035","volume":"74","author":"C Zhang","year":"2021","unstructured":"Zhang, C. et al. Involvement of TIGIT in natural killer cell exhaustion and immune escape in patients and mouse model with liver echinococcus multilocularis infection. Hepatology 74, 3376\u20133393 (2021).","journal-title":"Hepatology"},{"key":"50754_CR64","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13071-020-04541-0","volume":"14","author":"T Macak Kubaskova","year":"2021","unstructured":"Macak Kubaskova, T., Mudronova, D., Vargova, M., Reiterova, K. & Hrckova, G. Cellular and humoral peritoneal immunity to Mesocestoides vogae metacestode infection in mice. Parasites & vectors 14, 54 (2021).","journal-title":"Parasites & vectors"},{"key":"50754_CR65","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1186\/s13071-021-05006-8","volume":"14","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Granulocytic myeloid-derived suppressor cells inhibit T follicular helper cells during experimental Schistosoma japonicum infection. Parasit. Vectors 14, 497 (2021).","journal-title":"Parasit. Vectors"},{"key":"50754_CR66","doi-asserted-by":"publisher","first-page":"4716","DOI":"10.4049\/jimmunol.1601860","volume":"198","author":"Q Yang","year":"2017","unstructured":"Yang, Q. et al. A schistosoma japonicum infection promotes the expansion of myeloid-derived suppressor cells by activating the JAK\/STAT3 pathway. J. Immunol. 198, 4716\u20134727 (2017).","journal-title":"J. Immunol."},{"key":"50754_CR67","doi-asserted-by":"publisher","first-page":"4476","DOI":"10.1128\/IAI.00729-15","volume":"83","author":"S Bandyopadhyay","year":"2015","unstructured":"Bandyopadhyay, S. et al. Glycyrrhizic acid-mediated subdual of myeloid-derived suppressor cells induces antileishmanial immune responses in a susceptible host. Infect. Immun. 83, 4476\u20134486 (2015).","journal-title":"Infect. Immun."},{"key":"50754_CR68","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1189\/jlb.1110608","volume":"90","author":"WF Pereira","year":"2011","unstructured":"Pereira, W. F. et al. Myeloid-derived suppressor cells help protective immunity to Leishmania major infection despite suppressed T cell responses. J. Leukoc. Biol. 90, 1191\u20131197 (2011).","journal-title":"J. Leukoc. Biol."},{"key":"50754_CR69","doi-asserted-by":"publisher","first-page":"e1011329","DOI":"10.1371\/journal.ppat.1011329","volume":"19","author":"H Qi","year":"2023","unstructured":"Qi, H. et al. Tim-3 regulates the immunosuppressive function of decidual MDSCs via the Fyn-STAT3-C\/EBPbeta pathway during Toxoplasma gondii infection. PLoS Pathog. 19, e1011329 (2023).","journal-title":"PLoS Pathog."},{"key":"50754_CR70","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1007\/s00432-022-04036-8","volume":"148","author":"SA Bahwal","year":"2022","unstructured":"Bahwal, S. A. et al. Attenuated Toxoplasma gondii enhances the antitumor efficacy of anti-PD1 antibody by altering the tumor microenvironment in a pancreatic cancer mouse model. J. Cancer Res. Clin. Oncol. 148, 2743\u20132757 (2022).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"50754_CR71","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1158\/0008-5472.CAN-09-1882","volume":"70","author":"PY Pan","year":"2010","unstructured":"Pan, P. Y. et al. Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. Cancer Res. 70, 99\u2013108 (2010).","journal-title":"Cancer Res."},{"key":"50754_CR72","doi-asserted-by":"publisher","first-page":"5693","DOI":"10.4049\/jimmunol.0900092","volume":"182","author":"CA Corzo","year":"2009","unstructured":"Corzo, C. A. et al. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J. Immunol. 182, 5693\u20135701 (2009).","journal-title":"J. Immunol."},{"key":"50754_CR73","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1046\/j.1365-2567.2003.01567.x","volume":"108","author":"WJ Dai","year":"2003","unstructured":"Dai, W. J., Waldvogel, A., Jungi, T., Stettler, M. & Gottstein, B. Inducible nitric oxide synthase deficiency in mice increases resistance to chronic infection with Echinococcus multilocularis. Immunology 108, 238\u2013244 (2003).","journal-title":"Immunology"},{"key":"50754_CR74","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1046\/j.1365-2567.1999.00723.x","volume":"97","author":"WJ Dai","year":"1999","unstructured":"Dai, W. J. & Gottstein, B. Nitric oxide-mediated immunosuppression following murine Echinococcus multilocularis infection. Immunology 97, 107\u2013116 (1999).","journal-title":"Immunology"},{"key":"50754_CR75","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.immuni.2021.04.004","volume":"54","author":"S Hegde","year":"2021","unstructured":"Hegde, S., Leader, A. M. & Merad, M. MDSC: Markers, development, states, and unaddressed complexity. Immunity 54, 875\u2013884 (2021).","journal-title":"Immunity"},{"key":"50754_CR76","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1046\/j.1365-3024.1999.00243.x","volume":"21","author":"CM Dreweck","year":"1999","unstructured":"Dreweck, C. M., Soboslay, P. T., Schulz-Key, H., Gottstein, B. & Kern, P. Cytokine and chemokine secretion by human peripheral blood cells in response to viable Echinococcus multilocularis metacestode vesicles. Parasite Immunol. 21, 433\u2013438 (1999).","journal-title":"Parasite Immunol."},{"key":"50754_CR77","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1046\/j.1365-3024.2003.00601.x","volume":"25","author":"A Eger","year":"2003","unstructured":"Eger, A. et al. Pro-inflammatory (IL-1beta, IL-18) cytokines and IL-8 chemokine release by PBMC in response to Echinococcus multilocularis metacestode vesicles. Parasite Immunol. 25, 103\u2013105 (2003).","journal-title":"Parasite Immunol."},{"key":"50754_CR78","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1017\/S0022149X10000878","volume":"85","author":"MC Margos","year":"2011","unstructured":"Margos, M. C., Grandgirard, D., Leib, S. & Gottstein, B. In vitro induction of lymph node cell proliferation by mouse bone marrow dendritic cells following stimulation with different Echinococcus multilocularis antigens. J Helminthol 85, 128\u2013137 (2011).","journal-title":"J Helminthol"},{"key":"50754_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1032280","volume":"13","author":"R Meng","year":"2022","unstructured":"Meng, R. et al. Indoleamine 2,3-dioxygenase 1 signaling orchestrates immune tolerance in Echinococcus multilocularis-infected mice. Front. Immunol. 13, 1032280 (2022).","journal-title":"Front. Immunol."},{"key":"50754_CR80","doi-asserted-by":"publisher","first-page":"e0204868","DOI":"10.1371\/journal.pone.0204868","volume":"13","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Mechanisms underlying immune tolerance caused by recombinant Echinococcus granulosus antigens Eg mMDH and Eg10 in dendritic cells. PloS ONE 13, e0204868 (2018).","journal-title":"PloS ONE"},{"key":"50754_CR81","first-page":"111","volume":"29","author":"JY Shan","year":"2011","unstructured":"Shan, J. Y. et al. [Echinococcus granulosus recombinant antigen B induced IDO expression in mouse bone marrow-derived dendritic cells in vitro]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 29, 111\u2013116 (2011).","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi"},{"key":"50754_CR82","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/infdis\/jiq095","volume":"203","author":"LH Makala","year":"2011","unstructured":"Makala, L. H. et al. Leishmania major attenuates host immunity by stimulating local indoleamine 2,3-dioxygenase expression. J. Infect. Dis. 203, 715\u2013725 (2011).","journal-title":"J. Infect. Dis."},{"key":"50754_CR83","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1423-0127-19-5","volume":"19","author":"LH Makala","year":"2012","unstructured":"Makala, L. H. The role of indoleamine 2, 3 dioxygenase in regulating host immunity to leishmania infection. J. Biomed. Sci. 19, 5 (2012).","journal-title":"J. Biomed. Sci."},{"key":"50754_CR84","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cyto.2012.04.022","volume":"59","author":"Y Murakami","year":"2012","unstructured":"Murakami, Y. et al. Inhibition of increased indoleamine 2,3-dioxygenase activity attenuates Toxoplasma gondii replication in the lung during acute infection. Cytokine 59, 245\u2013251 (2012).","journal-title":"Cytokine"},{"key":"50754_CR85","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13045-021-01080-8","volume":"14","author":"K Tang","year":"2021","unstructured":"Tang, K., Wu, Y. H., Song, Y. & Yu, B. Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy. J. Hematol. Oncol. 14, 68 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"50754_CR86","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1158\/0008-5472.CAN-18-1106","volume":"79","author":"TA Werfel","year":"2019","unstructured":"Werfel, T. A. et al. Treatment-induced tumor cell apoptosis and secondary necrosis drive tumor progression in the residual tumor microenvironment through MerTK and IDO1. Cancer Res. 79, 171\u2013182 (2019).","journal-title":"Cancer Res."},{"key":"50754_CR87","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.4049\/jimmunol.0904094","volume":"185","author":"DM Kuang","year":"2010","unstructured":"Kuang, D. M. et al. Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients. J. Immunol. 185, 1544\u20131549 (2010).","journal-title":"J. Immunol."},{"key":"50754_CR88","doi-asserted-by":"publisher","first-page":"e1002594","DOI":"10.1371\/journal.ppat.1002594","volume":"8","author":"C Sun","year":"2012","unstructured":"Sun, C. et al. TGF-beta1 down-regulation of NKG2D\/DAP10 and 2B4\/SAP expression on human NK cells contributes to HBV persistence. PLoS Pathog. 8, e1002594 (2012).","journal-title":"PLoS Pathog."},{"key":"50754_CR89","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ccell.2019.02.008","volume":"35","author":"W Liao","year":"2019","unstructured":"Liao, W. et al. KRAS-IRF2 Axis drives immune suppression and immune therapy resistance in colorectal cancer. Cancer Cell 35, 559\u2013572. e557 (2019).","journal-title":"Cancer Cell"},{"key":"50754_CR90","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1002\/hep.30676","volume":"70","author":"YM Li","year":"2019","unstructured":"Li, Y. M. et al. Receptor-interacting protein kinase 3 deficiency recruits myeloid-derived suppressor cells to hepatocellular carcinoma through the chemokine (C-X-C Motif) ligand 1-chemokine (C-X-C Motif) receptor 2 axis. Hepatology 70, 1564\u20131581 (2019).","journal-title":"Hepatology"},{"key":"50754_CR91","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00177-22","volume":"90","author":"T Jiang","year":"2022","unstructured":"Jiang, T. et al. Single-cell heterogeneity of the liver-infiltrating lymphocytes in individuals with chronic echinococcus multilocularis infection. Infect. Immun. 90, e0017722 (2022).","journal-title":"Infect. Immun."}],"updated-by":[{"DOI":"10.1038\/s41467-024-51832-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50754-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50754-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50754-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T07:06:17Z","timestamp":1724828777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50754-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,27]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["50754"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-50754-7","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41467-024-51832-6","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,27]]},"assertion":[{"value":"2 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41467-024-51832-6","URL":"https:\/\/doi.org\/10.1038\/s41467-024-51832-6","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6345"}}